Pembrolizumab and All-Trans Retinoic Acid in Combination Treatment of Advanced Melanoma
Phase of Trial: Phase I/II
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Pembrolizumab (Primary) ; Tretinoin (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 14 Nov 2017 Status changed from not yet recruiting to recruiting.
- 13 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Oct 2017.
- 01 Aug 2017 Planned initiation date changed from 1 Aug 2017 to 1 Sep 2017.